vimarsana.com

Latest Breaking News On - Healthcare management analytics programme - Page 1 : vimarsana.com

health care: Zydus Lifesciences appoints Punit Patel as President & CEO, Americas

Before joining Zydus, he was the President of Red Oak Sourcing, leading the company s "multibillion-dollar generic portfolio", overseeing all aspects of Red Oak s business. Patel, who has more than 20 years of experience in the generics and branded pharmaceutical marketplace, has also worked at Novartis Vaccines & Diagnostics and CVS Caremark, Zydus said.

About 52 per cent cases of cervical cancer diagnosed from 2012-15 survived: Lancet Study

A study analyzing data from Population Based Cancer Registries (PBCRs) in India found that approximately 52% of cervical cancer cases diagnosed between 2012 and 2015 survived. Ahmedabad s urban PBCR had the highest survival rate at 61.5%, while Tripura had the lowest at 31.6%.

Blood cancer trust: CDSCO approves India s first CAR-T cell therapy against certain blood cancers

Indian company ImmunoACT, backed by drug maker Laurus Labs, has received approval from the Central Drugs Standard Control Organization for its CAR-T cell therapy NexCAR19. The therapy is the first of its kind to be developed in India and will be used to treat certain types of blood cancers. ImmunoACT intends to make the drug available to partner hospitals as soon as possible.

Zydus unit recalls 7,248 bottles of Oxybutynin Chloride tablets in US

New Jersey-based Zydus Pharmaceuticals (USA) Inc. is recalling the affected lot due to "Failed Dissolution Specifications", the USFDA stated. The lot was produced at Ahmedabad and distributed in the US by Zydus Pharmaceuticals (USA) Inc, the US health regulator stated.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.